Arcadia Capital Advisors, LLC

Arcadia Capital Advisors, LLC appears in our data through filings on CPEX Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 28 December 2009 and 16 February 2010, the trades on record add up to 15 filings.

In open-market terms, that means 10 purchases worth €460k on one side and 5 sales worth €642k on the other. On balance, insiders were net sellers of €182k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2010 to date brings 6 purchases and 5 sales.

Half of the purchases are above €29k and half below.

The record was last updated on 16 February 2010 with an open-market sale (€573k) in CPEX Pharmaceuticals, Inc. The most recent open-market purchase was published on 15 January 2010, 6,126 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.